Shin Nippon Biomedical Laboratories

Shin Nippon Biomedical Laboratories is one of the...

• Topix.

Shin Nippon Biomedical Laboratories is a company listed under the stock ticker 2395 (JP).

Acquisition, funding and merger involving Shin Nippon Biomedical Laboratories.

• Shin Nippon Biomedical Laboratories has announced the acquisition of Satsuma Pharmaceuticals  (posted on April 18 2023).

View the org chart displaying its 27 main executives

Most searched biographies at Shin Nippon Biomedical Laboratories

• Ryoichi Nagata, Chairman of the Board, Chief Executive Officer, Ch...
• Takashi Yamashita, Non-Executive Independent Director
• Shinichi Fukumoto, Non-Executive Independent Director

Create your alert
to follow the executive moves at Shin Nippon Biomedical Laboratories.

Shin Nippon Biomedical Laboratories has 2,290 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Delphia Therapeutics has just announced a $67 Million fundraising (posted on May 7 2024).
• Karius has just announced a $100 Million fundraising (posted on May 3 2024).
• Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Shin Nippon Biomedical Laboratories

• Financial News Archive-SNBL

Social media about Shin Nippon Biomedical Laboratories

• Shin Nippon Biomedical Laboratories on Wikipedia, Google News & Yahoo Finance
• Shin Nippon Biomedical Laboratories on LinkedIn, Twitter & YouTube

Contact by email its executives including Takashi Yamashita

Call Shin Nippon Biomedical Laboratories at +81 35...

View the org chart

Register to receive your alert

Report an error